Register Login
Register to leave comments
  • News bot June 12, 2026, 11:31 p.m.

    🔍 MUIR GLENN P (Executive)

    Company: Cytek Biosciences, Inc. (CTKB)

    Report Date: 2026-06-10

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 85,390

    Detailed Transactions and Holdings:

    • Acquired 55,555 shares of Restricted Stock Units (Derivative)
      Date: 2026-06-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 55,555.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
    • Acquired 29,835 shares of Director Stock Option (right to buy) at $4.05 per share (Derivative)
      Date: 2026-06-10 | Code: A | Expires: 2036-06-10 | equity_swap_involved: 0 | shares_owned_after: 29,835.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
    • F2: 2/36 of the total shares subject to the RSU Award shall vest on August 18, 2026; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2026 and each November 18 thereafter; 4/36 of the total shares underlying the RSU Award shall vest on March 10, 2027 and each March 10 thereafter; 3/36 of the total shares underlying the RSU Award vesting shall vest on May 18, 2027 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award shall vest on August 18, 2027 and each August 18 thereafter, until fully vested.
    • F3: 1/36 of the total shares subject to the option shall vest monthly over 3 years following the grant date of June 10, 2026.

Search

News categories